Skip to content
← Back to this collection

PUBLICATIONS · 21245435

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Mar 20
First author
O'Connor OA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      O'Connor OA
      type
      Author
    2. name
      Pro B
      type
      Author
    3. name
      Pinter-Brown L
      type
      Author
    4. name
      Bartlett N
      type
      Author
    5. name
      Popplewell L
      type
      Author
    6. name
      Coiffier B
      type
      Author
    7. name
      Lechowicz MJ
      type
      Author
    8. name
      Savage KJ
      type
      Author
    9. name
      Shustov AR
      type
      Author
    10. name
      Gisselbrecht C
      type
      Author
    11. name
      Jacobsen E
      type
      Author
    12. name
      Zinzani PL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      O'Connor OA
      type
      Author
    2. name
      Pro B
      type
      Author
    3. name
      Pinter-Brown L
      type
      Author
    4. name
      Bartlett N
      type
      Author
    5. name
      Popplewell L
      type
      Author
    6. name
      Coiffier B
      type
      Author
    7. name
      Lechowicz MJ
      type
      Author
    8. name
      Savage KJ
      type
      Author
    9. name
      Shustov AR
      type
      Author
    10. name
      Gisselbrecht C
      type
      Author
    11. name
      Jacobsen E
      type
      Author
    12. name
      Zinzani PL
      type
      Author
    bibliography ids
    1. nci-bib-8e36329d0bf64bcf5cb671ea
    book metadata
    content sha256
    7af9f2604791539d7a6137415e86de7945e0a918e5c236078d760ebd64df11b0
    document type
    citation
    dois
    1. 10.1200/JCO.2010.29.9024
    electronic publication date
    display
    2011 Jan 18
    precision
    day
    year
    2011
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21245435
    immutable id
    pubmed:21245435@7af9f2604791539d7a6137415e86de7945e0a918e5c236078d760ebd64df11b0
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    9
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1182-9
    volume
    29
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21245435
      provenance
      batch id
      edef4b7f1a2a505cd5a9
      provider
      NCBI PubMed ESummary
      record sha256
      3162b728de953bbff5ea5844ee81b17ad155b39577493f5e33e840ee4695de03
      response sha256
      d2d0fd7c34783716c953156f8a1da1b7b36c4823b416656eca04a1e69e03a295
      retrieved at
      2026-09-09T23:46:38.027615+00:00
      publication date
      display
      2011 Mar 20
      precision
      day
      year
      2011
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21245435/
      title
      Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.

      Preserved source evidence · Independent clinical review pending · Not medical advice